| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 12.5k | $16.30 | $203.8k | | 06/06/2023 |
| 05/10/2023 | Vera Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 20k | $7.70 | $154k | | 05/10/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 2.6k | $27.03 | $71k | | 01/03/2023 |
| 06/21/2022 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 12.5k | $12.26 | $153.2k | | 06/21/2022 |
| 05/24/2022 | Vera Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 9.9k | $16.14 | $160.2k | | 05/24/2022 |
| 01/03/2022 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 7.2k | $10.93 | $79.1k | | 01/03/2022 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Purchase | Common Stock | 357.1k | $14.00 | $5M | By Sofinnova Venture Partners X, L.P. | 07/01/2021 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Conversion | Series A Preferred Stock | 10.6M | $0.00 | $0 | By Sofinnova Venture Parnters X, L.P. | 07/01/2021 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Conversion | Common Stock | 3.4M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 07/01/2021 |
| 07/01/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 2.5k | $19.41 | $47.9k | | 07/01/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 2.2M | $0.00 | $0 | See footnote | 05/18/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 727.3k | $11.00 | $8M | See footnote | 05/18/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Conversion | Class A Common Stock | 2.2M | $0.00 | $0 | See footnote | 05/18/2021 |
| 05/13/2021 | Vera Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 9.9k | $11.00 | $109.2k | | 05/13/2021 |